Miromatrix Medical Inc. (MIRO) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for MIRO is $9.00, representing a +165.5% upside from the current price of $3.39. Price targets range from a low of $9.00 to a high of $9.00.
